Adaptation of vancomycin-resistant enterococci during bloodstream infection

血流感染期间耐万古霉素肠球菌的适应

基本信息

项目摘要

SUMMARY The long-term objective of this project is to understand how vancomycin-resistant enterococci (VRE) adapt during bloodstream infection (BSI) to better tolerate antibiotic and host immune defenses. Enterococci have evolved over hundreds of millions of years to colonize the gastrointestinal (GI) tract of animals, and they are well adapted to reside there. VRE causing BSI, however, face substantially different selective pressures, such as antibiotics in high concentrations, nutrient restriction, and host immune defenses. At our center over the past five years, patients with VRE-BSIs had a 30-day mortality rate of 36%, which was higher than BSIs due to all other ESKAPE pathogens. Additionally, VRE-BSIs are often difficult to treat, and nearly one third of patients with VRE- BSI experience either prolonged bacteremia (≥5 days), or recurrent infection within one year. Here we propose to study the population-level evolutionary dynamics of VRE sampled from the GI tract and blood of patients with VRE-BSI, and to characterize bacterial adaptations that promote VRE-BSI. Our central hypothesis is that VRE isolated from BSIs possess genetic adaptations that enable them to survive in the blood environment. In Aim 1, we will use bacterial population-level whole genome sequencing to identify genetic adaptations associated with VRE-BSI. We propose to collect matched samples from VRE GI tract surveillance specimens and VRE-BSI from approximately 150 patients, and to sequence them deeply to assess the diversity of the VRE population at each body site. We will also compare VRE-BSI populations collected over time from patients that have persistent or recurrent VRE-BSI. We will utilize comparative genomics and selection-based analyses to identify bacterial loci that are candidate targets for selection. In Aim 2, we will quantify the effect of mutations in VRE transcription and translation genes on antibiotic resistance and tolerance. We have already identified candidate adaptive mutations in RNA polymerase subunits, ribosomal proteins, a ribosome methyltransferase, and several transcriptional regulators. We will investigate: 1) The connection between antibiotic exposure and the occurrence of these mutations in the GI tract and blood of VRE-BSI patients, 2) The effects of these mutations on VRE transcription and translation, and 3) The contribution of these mutations to resistance and/or tolerance of antibiotics used to treat VRE-BSI. In Aim 3, we will determine whether mutations in the capsular polysaccharide (cps) and enterococcal polysaccharide antigen (epa) biosynthetic loci augment VRE growth and survival during BSI. We will investigate the impact of mutations that alter these cell surface-associated polysaccharides on VRE survival in whole human blood, in the presence of human neutrophils, as well as in a mouse model of VRE infection. Overall, this study has the potential to transform our understanding of how antibiotic-resistant bacteria adapt during human infection. In addition, the identification of bacterial genes and pathways under selection during VRE-BSI will lay the foundation for developing new therapeutic strategies that target antibiotic-resistant Gram-positive infections, which have high mortality and place a large burden on healthcare systems.
总结 该项目的长期目标是了解万古霉素耐药肠球菌(VRE)如何适应 在血液感染(BSI)期间,更好地耐受抗生素和宿主免疫防御。肠球菌有 经过数亿年的进化,它们在动物的胃肠道(GI)中定居,并且它们很好地 适合居住在那里。然而,引起BSI的VRE面临着基本上不同的选择性压力,例如 高浓度抗生素、营养限制和宿主免疫防御。在过去的五年里, 在2010年,VRE-BSI患者的30天死亡率为36%,高于所有其他原因导致的BSI。 ESKAPE病原体。此外,VRE-BSI通常难以治疗,近三分之一的VRE-BSI患者 BSI经历长期菌血症(≥5天)或在一年内复发感染。在这里我们建议 研究从胃肠道和血液中取样的VRE的群体水平进化动力学, VRE-BSI,并表征促进VRE-BSI的细菌适应。我们的中心假设是, 从BSIs中分离出来的细菌具有遗传适应性,使它们能够在血液环境中生存。在目标1中, 我们将使用细菌群体水平的全基因组测序来识别与以下疾病相关的遗传适应性: VRE-BSI。我们建议从VRE胃肠道监测标本和VRE-BSI中采集匹配样本, 大约150名患者,并对其进行深度测序,以评估每个阶段VRE人群的多样性。 身体部位。我们还将比较一段时间内从持续性或非持续性癫痫患者中收集的VRE-BSI人群, 复发性VRE-BSI。我们将利用比较基因组学和基于选择的分析来确定细菌位点 作为选择的候选目标。在目标2中,我们将量化VRE转录中突变的影响, 翻译基因对抗生素耐药性和耐受性的影响。我们已经确定了候选自适应 RNA聚合酶亚基、核糖体蛋白、核糖体甲基转移酶和几种 转录调节因子。我们将调查:1)抗生素暴露与发生之间的联系 VRE-BSI患者胃肠道和血液中的这些突变,2)这些突变对VRE的影响 转录和翻译,和3)这些突变对耐药性和/或耐受性的贡献。 用于治疗VRE-BSI的抗生素。在目标3中,我们将确定是否在荚膜多糖突变, (cps)和肠球菌多糖抗原(epa)生物合成位点增加VRE生长和存活, BSI。我们将研究改变这些细胞表面相关多糖的突变对VRE的影响。 在人全血中、存在人中性粒细胞时以及在VRE小鼠模型中的存活率 感染总的来说,这项研究有可能改变我们对抗药性细菌如何在体内生长的理解。 适应人类感染。此外,在选择下鉴定细菌基因和途径 在VRE-BSI期间,将为开发新的治疗策略奠定基础, 革兰氏阳性菌感染,死亡率高,给医疗保健系统带来沉重负担。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Daria N Van Tyne其他文献

Daria N Van Tyne的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Daria N Van Tyne', 18)}}的其他基金

Deciphering the genetic basis of differential antibiotic efficacy in Enterococcus faecalis endocarditis
破译抗生素对粪肠球菌心内膜炎疗效差异的遗传基础
  • 批准号:
    10597129
  • 财政年份:
    2022
  • 资助金额:
    $ 58.2万
  • 项目类别:
Deciphering the genetic basis of differential antibiotic efficacy in Enterococcus faecalis endocarditis
破译抗生素对粪肠球菌心内膜炎疗效差异的遗传基础
  • 批准号:
    10452049
  • 财政年份:
    2022
  • 资助金额:
    $ 58.2万
  • 项目类别:
Carbonic anhydrase inhibition as a target for antibiotic synergy in enterococci
碳酸酐酶抑制作为肠球菌抗生素协同作用的目标
  • 批准号:
    10591694
  • 财政年份:
    2022
  • 资助金额:
    $ 58.2万
  • 项目类别:
Bacterial Evasion of Innate Defenses at the Ocular Surface
细菌逃避眼表的先天防御
  • 批准号:
    10011825
  • 财政年份:
    2018
  • 资助金额:
    $ 58.2万
  • 项目类别:

相似海外基金

The effects of antibiotics to the transfer frequency of the antibiotic resistance genes and the evolution of high-level resistance.
抗生素对抗生素抗性基因转移频率和高水平抗性进化的影响。
  • 批准号:
    22K05790
  • 财政年份:
    2022
  • 资助金额:
    $ 58.2万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
NEC05839 Chicken or the Egg: Is AMR in the Environment Driven by Dissemination of Antibiotics or Antibiotic Resistance Genes?
NEC05839 先有鸡还是先有蛋:环境中的抗菌素耐药性是由抗生素或抗生素抗性基因的传播驱动的吗?
  • 批准号:
    NE/N019687/2
  • 财政年份:
    2019
  • 资助金额:
    $ 58.2万
  • 项目类别:
    Research Grant
Combating Antibiotic Resistance to Aminoglycoside Antibiotics through Chemical Synthesis
通过化学合成对抗氨基糖苷类抗生素的耐药性
  • 批准号:
    392481159
  • 财政年份:
    2017
  • 资助金额:
    $ 58.2万
  • 项目类别:
    Research Fellowships
NEC05839 Chicken or the Egg: Is AMR in the Environment Driven by Dissemination of Antibiotics or Antibiotic Resistance Genes?
NEC05839 先有鸡还是先有蛋:环境中的抗菌素耐药性是由抗生素或抗生素抗性基因的传播驱动的吗?
  • 批准号:
    NE/N019687/1
  • 财政年份:
    2016
  • 资助金额:
    $ 58.2万
  • 项目类别:
    Research Grant
Chicken or the Egg: Is AMR in the Environment Driven by Dissemination of Antibiotics or Antibiotic Resistance Genes?
先有鸡还是先有蛋:环境中的抗菌素耐药性是由抗生素或抗生素抗性基因的传播驱动的吗?
  • 批准号:
    NE/N019857/1
  • 财政年份:
    2016
  • 资助金额:
    $ 58.2万
  • 项目类别:
    Research Grant
The SuDDICU study- A study of the impact of preventative antibiotics (SDD) on patient outcome and antibiotic resistance in the critically ill in intensive care
SuDDICU 研究 - 一项关于预防性抗生素 (SDD) 对重症监护病危患者的患者预后和抗生素耐药性影响的研究
  • 批准号:
    366555
  • 财政年份:
    2016
  • 资助金额:
    $ 58.2万
  • 项目类别:
    Operating Grants
Chicken or the Egg: Is AMR in the Environment Driven by Dissemination of Antibiotics or Antibiotic Resistance Genes?
先有鸡还是先有蛋:环境中的抗菌素耐药性是由抗生素或抗生素抗性基因的传播驱动的吗?
  • 批准号:
    NE/N019717/1
  • 财政年份:
    2016
  • 资助金额:
    $ 58.2万
  • 项目类别:
    Research Grant
The SuDDICU study- A study of the impact of preventative antibiotics (SDD) on patient outcome and antibiotic resistance in the critically ill in intensive care
SuDDICU 研究 - 一项关于预防性抗生素 (SDD) 对重症监护病危患者的患者预后和抗生素耐药性影响的研究
  • 批准号:
    361307
  • 财政年份:
    2016
  • 资助金额:
    $ 58.2万
  • 项目类别:
    Operating Grants
RAPID: COLLABORATIVE RESEARCH: Fate and Transport of Antibiotics and Antibiotic Resistance Genes During Historic Colorado Flood
快速:合作研究:历史性科罗拉多洪水期间抗生素和抗生素抗性基因的命运和运输
  • 批准号:
    1402635
  • 财政年份:
    2013
  • 资助金额:
    $ 58.2万
  • 项目类别:
    Standard Grant
Contamination status of antibiotics and antibiotic resistance genes (ARGs) in tropical Asian aquatic environments with artificial and natural disturbance
人工和自然干扰下亚洲热带水生环境中抗生素和抗生素抗性基因(ARG)的污染状况
  • 批准号:
    25257402
  • 财政年份:
    2013
  • 资助金额:
    $ 58.2万
  • 项目类别:
    Grant-in-Aid for Scientific Research (A)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了